Influenza in the tropics - Epidemiology and burden  by Da Silva, L. & Kyaw, M.H.
e th In
i
s
p
c
d
r
t
a
t
d
t
o
e
C
(
w
(
r
m
T
p
w
i
d
2
N
i
V
t
s
S
C
P
b
A
n
r
v
v
b
U
S
a
m
c
2
ﬁ
A
A
b
D
N
i
o
i
t
-
N
z
A
r
t
v
r
i
a
o
d
2
I
L
b
a
t
e
a
r
t
t
r
d
s
b
g
t
1
c
a
d
2
o
l
i
a
‘
T
t
c
s
c86 14
nﬂuenza patients with one or more high-risk co morbidities.
Methods: The study was a double-blind, multi-center
tudy of intravenous peramivir with dosing over multi-
le days. The study enrolled 42 inﬂuenza patients with
omplications due to one or more qualifying conditions:
iagnosis with poorly controlled diabetes mellitus, a chronic
espiratory disease requiring pharmacotherapy, or current
reatment with any immunosuppressive drug. Peramivir was
dministered at 300mg or 600mg per day, and the dura-
ion was adjusted (up to ﬁve days) on a case-by-case basis,
epending on the patient’s temperature and clinical condi-
ion as determined by the treating physician.
Results: In this study, the median time to alleviation
f symptoms in all 37 evaluable patients treated with
ither 300mg or 600mg peramivir daily was 68.6 hrs (90%
I, 41.5 hrs - 113.4 hrs). The median time for each group
300mg and 600mg) was 114.4 hrs and 42.3 hrs respectively,
hile the time for each group categorized as single-dosed
n = 10) and multipledosed (n = 27) was 92.0 hrs and 64.1 hrs,
espectively. The incidence of pneumonia, which was the
ain complication resulting from inﬂuenza was 8.1% (3/37).
here were no drugrelated SAEs throughout the study.
Conclusion: The results suggest that intravenous
eramivir was effective for treatment of inﬂuenza patients
ith a high-risk for complications co morbidities and
ncreased risk for complications due to inﬂuenza infection.
oi:10.1016/j.ijid.2010.02.1678
8.009
euraminidase sub typing and drug resistance among
nﬂuenza A viruses circulating in western India
. Potdar ∗, M. Dakhave, M. Chadha, A. Mishra
National Institute of Virology, 421001, India
Background: Inﬂuenza viruses are important respira-
ory pathogens in India. Clinical, virological and molecular
urveillance is being carried out under a Multi- site Inﬂuenza
urveillance project (Indian Council of Medical Research-
enters for Diseases Control). National Institute of Virology,
une, India monitors genetic variations and drug suscepti-
ility in circulating inﬂuenza viruses. Most of the inﬂuenza
viruses are amantadine resistance worldwide and hence
euraminidase inhibitors (NAI) oseltamivir or zanamivir are
ecommended for the treatment of infection with inﬂuenza
iruses.
Methods: Neuraminidase sub typing of 42 H1 and 48 H3
iruses from the year 2003 to April 2009 were carried out
y one step diagnostic RT PCR using published primers.
niversal M13 primers forward and reverse were used for
equencing and subtypes of isolates were conﬁrmed by blast
nalysis. 253 bp product of N1 isolates contains established
utation site H274Y leading to oseltamivir resistance .To
heck the mutation sites E119V, I222V, R292K, N294S and -
44-247 for N2 isolates; further 1103 bp N2 gene was ampli-
ed using speciﬁc primers.
Results: NA Subtyping: 90 inﬂuenza A isolates from 2003-pril 2009 circulating in Pune were ampliﬁed. 90 inﬂuenza
isolates were conﬁrmed as 42 N1 and 48 N2 respectively
y sequencing. No unusual combinations were observed
etection of drug resistant sites for N1 and N2 isolates:
c
m
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1 isolates:253 bp ampliﬁed product of N1 isolates which
ncluded the established mutation site H274Y leading to
seltamivir resistance was analyzed by sequencing. All N1
solates were sensitive to oseltamivir. N2 isolates: To check
he mutation sites for N2 (E119V, I222V, R292K, N294S and
244- 247); further 1103 bp products were ampliﬁed. All 44
2 isolates were sensitive to both the drugs oseltamivir and
anamivir.
Conclusion: All seasonal inﬂuenza A viruses A/H1N1 and
/H3N2 were sensitive to neuraminidase inhibitors. Antivi-
al drugs against inﬂuenza are rarely used in India as a
herapeutic agent. However due to globalization, resistant
iruses could be seeded in Pune from elsewhere.Though no
esistant viruses were detected, continuous surveillance of
nﬂuenza viruses is needed to monitor circulating strains,
nd their drug susceptibility in view of pandemic potential
f inﬂuenza virus.
oi:10.1016/j.ijid.2010.02.1679
8.010
nﬂuenza in the tropics - Epidemiology and burden
. Da Silva ∗, M.H. Kyaw
Novartis Vaccines and Diagnostics, Cambridge, MA, USA
Background: Although inﬂuenza presents a signiﬁcant
urden in the tropics, the belief that this disease primarily
ffects people in temperate climates and developed coun-
ries persists because of peculiar circumstances of disease
pidemiology, other local causes of morbidity and mortality,
nd better surveillance systems in countries in temperate
egions. The public health burden of inﬂuenza is high in the
ropics, particularly in children, yet it has been suggested
hat vaccination programs would not be cost-effective in this
egion because little is known about the true impact of the
isease.
Methods: Systematic literature review of Medline using
earch terms of inﬂuenza, tropical, and epidemiology.
Results: In Medline, 155 manuscripts were published
etween 1969 and 2009. Inﬂuenza in tropical regions has
ained more attention in the medical literature in the
wenty-ﬁrst century; 118 of 155 papers (76%) appeared after
999. Twenty-three studies presented data on laboratory-
onﬁrmed cases of inﬂuenza in tropical regions. Outbreaks
nd epidemics present a signiﬁcant public health bur-
en in tropical regions. For example, in Madagascar in
002, more than 27,000 cases of inﬂuenza and 800 deaths
ccurred within a period of three months despite rapid pub-
ic health intervention. In tropical regions, viral transmission
s usually year-round and commonly has two peaks annu-
lly. Co-circulation of what are considered ‘‘northern’’ or
‘southern’’ strains occurs year-round in tropical regions.
ropical regions, thus, may be the source of new strains
hat are then disseminated to other latitudes. However, the
linical characteristics, impact on healthcare services, and
easonal variation of inﬂuenza in tropical regions are still not
learly understood, based on the current literature. A third
ategory of strain recommendation for inﬂuenza vaccines
ay be needed for tropical regions.
Conclusion: The burden of inﬂuenza in tropical countries
ay be higher than in North America or Europe. More stud-
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ies in the tropics are necessary to deﬁne the impact and
seasonality of inﬂuenza in these regions. These data could
help identify the optimal timing of vaccination programs and
other measures for the prevention and control of seasonal
and pandemic inﬂuenza in the tropics, including protection
for travelers and control of emerging strains.
doi:10.1016/j.ijid.2010.02.1680
28.011
Novel inﬂuenza A H1N1 (NIA) infection in Argentinean
Children — Experience at Hospital de Nin˜os ‘‘Ricardo
Gutiérrez’’
E.L. Lopez ∗, A. Fallo, M.M. Contrini, A. Mistchenko, C.
Molise, S. Neyro, N. Gonzalez, D. Lazzarini, G. Manonelles,
J. Grichener, M. Dastugue, A. Teper, N. Study Group
Hospital de Nin˜os ‘‘Ricardo Gutiérrez’’, Buenos Aires,
Argentina
Background: NIA pandemia (P) began in Argentina dur-
ing respiratory virus season. Hospital Gutiérrez (HG) set
up special outﬁtted examination room trailler; 5000 sus-
pected cases were attended in 2 mo. Health care for P
included 2 different stages: May24-June12, 695 outpatients
mainly school-age were attended [Containment Phase(CP)].
After 17 ds with a widespread disease: June12-July11, 110
children were admitted to HG due to respiratory failure [Mit-
igation Phase(MP)]
Objective: to characterize clinical, lab and treatment of
conﬁrmed NIA patients (pts)
Methods: IFA was used to rule out other RV; conﬁrmation
by RT-PCR
Results: CP: 220/695(61.3%) cases were conﬁrmed;
191students, 15 close contacts (CC), 8 international trav-
elers, 3 teachers; 2 health-workers. The 191 conﬁrmed
student cases are reported: mean age: 9± 3(4-17) yr; 16(8%)
had comorbidity(C). Most frequent symptoms: fever(F)
178(93%) and cough(Co)160(64%). Oseltamivir(Os) was pre-
scribed to 150(78.5%); none of them was hospitalized.
Duration of F and Co was lower in treated than untreated 2,1
vs 3.6 ds, and 4.2 vs 7 ds respectively(p < 0.001). Secondary
cases occurred in 41/297(15%) of CC, 12/31 in CC without
Os prophylaxis (OsP) and 29/266 in CC with OsP(p = 0.0002).
Mild adverse events(AE) by Os were reported in 12% of
treated pts and in 6.3% of CC
MP: 110 NIA cases represented 6.9% of admis-
sions during this period (double of usual seasonal ﬂu
cases/yr). Mean age 43.4(±54.4) mo; 61(55.5%) were
younger than 24 mo. Main symptoms on admission: F
106(97.4%) and bronchiolitis 70(63.6%). C was present in
84/110(76.4%), it was more frequent in children > 24 mo:
38/61(62.3%) than younger 46/49(93.9%)(p < 0.0003). Fif-
teen(13,6%) required ICU. Complications: 69/110(62.7%)
pts; pneumonia 52/110(47.3%); pneumonitis 31/110(28.2%)
[16/52(30.8%) had both X-Ray patterns]; encephalitis 1/110
(0.9%). Os treatment: 108(98.2%); AE 1/108(0.9%): unspe-
ciﬁc exanthema. Mortality 6/110(5.5%); all of them had C;
median age:87mo
Conclusion: NIA was mild in school-age pts
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Admissions by NIA were twice higher than seasonal ﬂu
nnually
Os was well tolerated by children
Os statistically reduced duration of F and Co
Os was effective to prevent secondary cases in CC
Mortality was low in hospitalized children, associated to
omorbidity
oi:10.1016/j.ijid.2010.02.1681
8.012
ssessing the risk of Inﬂuenza virus strains isolated from
irds and mammals to humans
. Vdovichenko1,∗, A. Sergeev1, O.K. Demina1, A.
abanov1, A.S. Kudriavcev2, A.V. Pal’cev2, U.E. Narov2,
.N. Shishkina1, I.G. Drozdov1
FRSI State research center of virology and biotechnology
‘Vector’’, Novosibirsk, Russian Federation
Novosibirsk Regional Oncological Clinic, Novosibirsk, Rus-
ian Federation
Background: Inﬂuenza A virus is the subject of research
f many scientists in the world. So now the attention of sci-
ntists focused on the problem of inﬂuenza, ﬁrst because
f the increased outbreaks of avian inﬂuenza in the world
nd the incidence of transmission of the disease to people
ho were in contact with sick birds. Secondly the threat
oday is the inﬂuenza virus of H1N1 subtype, which caused
any diseases among people around the world. In this con-
ection assessment of risk to human inﬂuenza virus strains
f various origins is essential for timely implementation of
ffective anti-epidemic measures in order to prevent the
evelopment of an epidemic or pandemic inﬂuenza. We have
valuated parameters of infectivity of inﬂuenza virus strains
H5N1, H1N1 and H3N2 subtypes) for primary cell culture
btained from human lung tissues.
Methods: Three inﬂuenza A/Chicken/Suzdalka/2/05
H5N1), A/Novosibirsk/1/09 (H1N1) and A/Aichi/2/68
H3N2) virus strains from the collection of research insti-
ute of FRSI SRC VB ‘‘Vector’’ and primary cell cultures
btained from pieces of human lung tissue kindly provided by
olleagues from the Regional Oncology Center of the Novosi-
irsk, Russia have been used.
Results: A comparison of the values 50% cell infect-
ng dose (CID50) of strains found that the susceptibility
f human lung cells to inﬂuenza A/Chicken/Suzdalka/2/05
irus strain in the 10 and 100 times more than values both
/Novosibirsk/1/09 and A/Aichi/2/68 virus strains respec-
ively. However inﬂuenza A/Chicken/Suzdalka/2/05 strain
ad a 10 times lower progeny yield during 20 hours of repli-
ation in human lung cells compared with other strains.
Conclusion: Thus, our studies revealed inﬂuenza
/Chicken/Suzdalka/2/05 virus strain is able to
ore easily infect cells of the respiratory tract of
an, but has a lower replicate activity than both
/Novosibirsk/1/09 and A/Aichi/2/68 virus strains.
nﬂuenza A/Chicken/Suzdalka/2/05 virus strain was iso-
ated during an outbreak of avian ﬂu among wild birds and
oultry in the Novosibirsk region. During this period of the
utbreak have not been established cases of avian inﬂuenza
ransmission from birds to local residents. Perhaps this is due
